Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

CANBRIDGE-B

3.100
+0.0100.32%
Volume:10.27M
Turnover:32.80M
Market Cap:1.58B
PE:-2.98
High:3.360
Open:3.050
Low:3.030
Close:3.090
52wk High:3.500
52wk Low:0.114
Shares:511.00M
HK Float Shares:511.00M
Volume Ratio:1.23
T/O Rate:2.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.042
ROE:-281.91%
ROA:-57.53%
PB:-3.43
PE(LYR):-2.98
PS:22.41

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
CANBRIDGE-B
Exchange:
SEHK
Establishment Date:
2012
Employees:
45
Office Location:
Suzhou Industrial Park, Building 21,Unit 18, 6th Floor,No. 388 Xinping Street,Suzhou,China
Website:
http://www.ssitimber.com.hk
Zip Code:
- -
Phone:
86 10 6478 0016
Fax:
- -
Introduction:
CANbridge Pharmaceuticals Inc. is a global biopharmaceutical company. It is focused on research, development and commercialization of transformative therapies for rare disease. It has a drug portfolio, with three approved drugs and a pipeline of eight assets, targeting rare disease indications that have unmet needs. These include Hunter syndrome and other lysosomal storage disorders, paroxysmal nocturnal hemoglobinuria and other complement-mediated disorders, hemophilia A, metabolic disorders, rare cholestatic liver diseases and neuromuscular diseases. Its pipeline includes Hunterase, Livmarli, CAN106, and CAN103. Hunterase is an enzyme replacement therapy for the treatment of Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome. Livmarli an oral, minimally absorbed, reversible inhibitor of the ileal bile acid transporter that is under development to treat rare cholestatic liver diseases including Alagille syndrome and progressive familial intrahepatic cholestasis.

Directors

Name
Position
XUE Qun
Chairman of the Board,Executive Director,Chairman of the Nomination Committee
James Arthur Geraghty
Independent Director,Member of the Nomination Committee,Audit Committee Member
Richard James Gregory
Independent Director,Chairman of the Remuneration and Assessment Committee,Audit Committee Member
CHEN Bing Jun
Independent Director,Member of the Nomination Committee,Audit Committee Chairman
HU Lan
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee
ZHAO Wei
Director,Member of the Remuneration and Assessment Committee
WANG Ting Wei
Director,Member of the Nomination Committee

Shareholders

Name
Position
XUE Qun
CEO
MA Qian
Corporate Secretary
HUANG Wei Chao
Corporate Secretary
Gerald Cox
Other Senior Executives,Other Senior Executives